Page results
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease. It outlines the importance of having your heart checked as part of your care.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
UCLH will play a vital role in a new respiratory virus study.
File results
-
FOI/2024/0042 - CT and MRI machines at Trust from 2019-2023
-
FOI/2024/0043 - Derogations following junior doctors strikes
-
FOI/2024/0046 - Translation and interpreting from 2019/20 to 2022/23
-
FOI/2024/0050 - Various patient transport services procured
-
FOI/2024/0053 - Pharmacy, prescribing and medicines strategy
-
FOI/2024/0056 - MRI examinations performed in 2023
-
FOI/2024/0059 - Late effects of cancer service
-
FOI/2024/0060 - Procurement contract register and procurement strategy
-
FOI/2024/0061 - 24 hour waits at A&E from 2019 to 2023
-
FOI/2024/0063 - Clinicians and nurses trained in treating patients with sodium nitrite poisoning